Facet browsing currently unavailable
Page 1 of 3094 results
Sort by: relevance publication year
Carbon Nanotubes in the Diagnosis and Treatment of Malignant Melanoma JOURNAL ARTICLE published 1 December 2012 in Anti-Cancer Agents in Medicinal Chemistry |
Editorial (Hot Topic: Recent Development of Molecular Targeted Anti-Cancer Agents) JOURNAL ARTICLE published 1 January 2013 in Anti-Cancer Agents in Medicinal Chemistry |
Advances in the Systemic Treatment of Neuroendocrine Tumors in the Era of Molecular Therapy JOURNAL ARTICLE published 31 January 2013 in Anti-Cancer Agents in Medicinal Chemistry |
Combination of DC Vaccine and Conventional Chemotherapeutics JOURNAL ARTICLE published 17 March 2016 in Anti-Cancer Agents in Medicinal Chemistry |
Anti-Tumour Activity of Glycodendrimer Nanoparticles in a Subcutaneous MEC-1 Xenograft Model of Human Chronic Lymphocytic Leukemia JOURNAL ARTICLE published 24 April 2020 in Anti-Cancer Agents in Medicinal Chemistry Research funded by H2020 European Institute of Innovation and Technology (http://dx.doi.org/10.13039/100010686) |
New Poly(3-hydroxybutyrate) Microparticles with Paclitaxel Sustained Release for Intraperitoneal Administration JOURNAL ARTICLE published 20 February 2017 in Anti-Cancer Agents in Medicinal Chemistry |
Syntetic Oligosacharides – Clinical Application in Cancer Therapy JOURNAL ARTICLE published 1 May 2013 in Anti-Cancer Agents in Medicinal Chemistry |
Molecular Field Analysis (MFA) and Other QSAR Techniques in Development of Phosphatase Inhibitors JOURNAL ARTICLE published 1 January 2011 in Anti-Cancer Agents in Medicinal Chemistry |
Targeting CD47 Inhibits Tumor Development and Increases Phagocytosis in Oral Squamous Cell Carcinoma JOURNAL ARTICLE published April 2021 in Anti-Cancer Agents in Medicinal Chemistry Research funded by National Natural Science Foundation of China (81771080,81970949) |
A Fluorescent Alkyllysophospholipid Analog Exhibits Selective Cytotoxicity Against the Hormone-Insensitive Prostate Cancer Cell Line PC3 JOURNAL ARTICLE published April 2014 in Anti-Cancer Agents in Medicinal Chemistry |
In Vitro Anticancer Evaluation of Platinum(II/IV) Complexes with Diisoamyl Ester of (S,S)-ethylenediamine-N,N’-di-2-propanoic Acid JOURNAL ARTICLE published 28 July 2017 in Anti-Cancer Agents in Medicinal Chemistry |
Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells JOURNAL ARTICLE published 12 September 2017 in Anti-Cancer Agents in Medicinal Chemistry |
The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway JOURNAL ARTICLE published 3 July 2020 in Anti-Cancer Agents in Medicinal Chemistry Research funded by Shahid Beheshti University of Medical Sciences, Tehran, Iran (9556) |
Graph Theoretical analysis, in silico modeling and molecular dynamic studies of (5-((2-chloropyridin-4-yl)oxy)-3-phenyl-1H-pyrazol-1-yl)-2-(4-substituted phenyl)-N,N-dimethylethen-1-amine derivatives for the treatment of breast cancer JOURNAL ARTICLE published 5 December 2022 in Anti-Cancer Agents in Medicinal Chemistry |
The Synergistic Cytotoxic and Apoptotic Effect of Resveratrol and Naringenin on Y79 Retinoblastoma Cell Line JOURNAL ARTICLE published November 2021 in Anti-Cancer Agents in Medicinal Chemistry |
Correction: Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis JOURNAL ARTICLE published 8 May 2019 in Anti-Cancer Agents in Medicinal Chemistry |
Exogenous Expression of WNT7A in Leukemia-Derived Cell Lines Induces Resistance to Chemotherapeutic Agents JOURNAL ARTICLE published 7 September 2020 in Anti-Cancer Agents in Medicinal Chemistry Research funded by Fondo de Investigación en Salud –IMSS (FIS/IMSS/PROT/G13/1243,FIS/IMSS/PROT/G14/1316) |
Preface JOURNAL ARTICLE published 1 January 2012 in Anti-Cancer Agents in Medicinal Chemistry |
In Silico Docking of Anti Cancerous Drugs with β-Cyclodextrin polymer as a Prominent Approach to Improve the Bioavailability JOURNAL ARTICLE published 11 June 2021 in Anti-Cancer Agents in Medicinal Chemistry |
Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors JOURNAL ARTICLE published July 2022 in Anti-Cancer Agents in Medicinal Chemistry Research funded by University Grant Commission (UGC), New Delhi, India, Rajiv Gandhi National Fellowship (F117.1/201617/RGNF201517-SCDEL23977) |